Free Radical Mechanism in Obesity Potentiation of Environmental Hepatotoxicity
肥胖环境肝毒性增强中的自由基机制
基本信息
- 批准号:8708077
- 负责人:
- 金额:$ 24.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-17 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:Autoimmune ProcessCYP2E1 geneCell DeathChemosensitizationChronicDevelopmentDietDisinfectionDoseEnvironmentEnvironmental ExposureEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesExposure toFatty LiverFree Radical FormationFree RadicalsGenerationsGranulocyte-Macrophage Colony-Stimulating FactorHepatotoxicityIn VitroIndividualInflammationInflammatoryInstructionInterferon Type IIInterferonsIsoenzymesKnockout MiceLeadLeptinLipid PeroxidationMacrophage ActivationMusNADPH OxidaseObese MiceObesityPopulationProteinsPublic HealthResearch Project GrantsRiskRisk FactorsRoleSteatohepatitisSystemTestingToxic Environmental SubstancesTranslationsTumor Necrosis Factor-alphaUnited Statesadductdietary restrictionhepatotoxinhuman TNF proteinin vivoliver injuryneutralizing antibodynoveloxidationresearch studyresponse
项目摘要
Obesity associated Nonalcoriolic steatohepatitis (NASH), has become a growing public health concern with increased obesity population in the United States. Progression from steatosis (fatty liver) to steatohepatitis (fatty liver with inflammation) is thought to require a second hit. This second hit can be provided by environmental exposure to hepatotoxins that are reductively metaboiized to form reactive free radicals. Although direct exposure to high doses of environmental hepatotoxins is rare, low exposure from the environment is more com.mon. Low doses may be well tolerated by normal healthy individuals but can be potential risk factors for inflammatory liver injuries like steatohepatitis in obese persons. Thus the long term objective of this research project is to test the hypothesis that low hepatotoxin exposure from the environment can potentiate the risk of progression of steatohepatitis in obese mice. The hypothesis will be tested in three specific aims that include investigating the mechanism of free radical formation and post-translation oxidation adducts of proteins in obese mice in response to the disinfection byproduct (DBP) bromodichloromethane (BDCM). The specific aims will be achieved by using inhibitors of enzymes such as NADPH oxidase and the Cyp450 isozyme CYP2E1 and with knockout mice lacking each of these enzymes. All studies in obesity will be carried out in diet-induced obese (DIG) mice and compared to diet-restricted lean controls. In Aim 2, 1 shall examine how initial lipid peroxidation, interferon-gamma (IFN-y) and granulocyte macrophage colony stimulating factor (GMCSF) lead to activation of macrophages and contribute to the second wave of generation of free radical damage and TNF-alpha secretion following BDCM exposure. This aim will be achieved through experiments using both in vivo and in vitro systems, in aim 3, I shall investigate the role of the proinflammatory adipocytokine leptin in synergizing the effect of environmental hepatotoxins such as bromodichloromethane, a DBP, This aim will be achieved by investigating free radical-induced macrophage activation and cell death in Ieptin knockout mice and using neutralizing antibodies against Ieptin.
与肥胖相关的非氧化脂肪性肝炎(NASH)已成为美国肥胖人群增加的日益增长的公共卫生问题。从脂肪变性(脂肪肝)到脂肪性肝炎(炎症脂肪肝)的进展被认为需要第二次打击。第二次命中可以通过对环境暴露于还原为形成反应性自由基的肝毒素。尽管直接接触高剂量的环境肝毒素是很少见的,但环境的暴露率很低。正常健康个体可能会耐受低剂量的耐受性,但可能是炎症性肝损伤的潜在危险因素,例如肥胖者的脂肪性肝炎。因此,该研究项目的长期目标是检验以下假设:肥胖小鼠中肝炎的肝毒素暴露低可增强脂肪性肝炎的风险。该假设将在三个特定目的中进行检验,包括研究肥胖小鼠中蛋白质自由基形成的机制和响应消毒副产物(DBP)溴迪基氯甲烷(BDCM)的机制。通过使用诸如NADPH氧化酶和CYP450同工酶CYP2E1的酶的抑制剂以及缺少每种酶的敲除小鼠,将实现具体目标。肥胖症的所有研究都将在饮食引起的肥胖(挖掘)小鼠中进行,并将其与饮食受限的瘦对手进行比较。在AIM 2中,1应研究初始脂质过氧化,干扰素 - γ(IFN-Y)和粒细胞巨噬细胞群落刺激因子(GMCSF)导致巨噬细胞的激活,并有助于第二波自由基损伤和BDCM暴露后的TNF-Alpha分泌。在AIM 3中,我将通过使用体内和体外系统的实验来实现这一目标抗ieptin的抗体。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Saurabh Chatterjee其他文献
Saurabh Chatterjee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Saurabh Chatterjee', 18)}}的其他基金
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10291806 - 财政年份:2019
- 资助金额:
$ 24.89万 - 项目类别:
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10426233 - 财政年份:2019
- 资助金额:
$ 24.89万 - 项目类别:
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10782703 - 财政年份:2019
- 资助金额:
$ 24.89万 - 项目类别:
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
9920633 - 财政年份:2019
- 资助金额:
$ 24.89万 - 项目类别:
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments
CMA:免疫/炎症引发加剧对 GWVI 应激源的反应:对 GWVI 治疗的影响
- 批准号:
10683720 - 财政年份:2019
- 资助金额:
$ 24.89万 - 项目类别:
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease
选定的受气候变化影响的病原体和污染物对重要器官、炎症和人类疾病的影响
- 批准号:
10443655 - 财政年份:2018
- 资助金额:
$ 24.89万 - 项目类别:
Effects of selected climate change-affected pathogens and pollutants on Critical Organs, Inflammation and Human disease
选定的受气候变化影响的病原体和污染物对重要器官、炎症和人类疾病的影响
- 批准号:
10218177 - 财政年份:2018
- 资助金额:
$ 24.89万 - 项目类别:
Free Radical Mechanism in Obesity Potentiation of Environmental Hepatotoxicity
肥胖环境肝毒性增强中的自由基机制
- 批准号:
8471883 - 财政年份:2012
- 资助金额:
$ 24.89万 - 项目类别:
Free Radical Mechanism in Obesity Potentiation of Environmental Hepatotoxicity
肥胖环境肝毒性增强中的自由基机制
- 批准号:
8532898 - 财政年份:2012
- 资助金额:
$ 24.89万 - 项目类别:
相似国自然基金
构建CYP2E1基因修饰大鼠模型,研究CYP2E1介导的糖代谢在心衰发生发展中的作用与机制
- 批准号:31872314
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
CYP2E1、SOD2基因多态性与抗结核药物所致肝损伤易感性的相关性及其细胞分子机制的研究
- 批准号:81400006
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
CYP2E1 通过糖代谢网络调控肥胖与酒精协同增效性脂肪肝炎中促炎性巨噬细胞基因表达和活化
- 批准号:81370531
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
基于模型大鼠酒精性肝损伤CYP2E1基因调控机制的乌腺金丝桃组分配伍研究
- 批准号:81202638
- 批准年份:2012
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A human Liver-on-a-Chip model for studying alcohol-associated liver disease
用于研究酒精相关肝病的人类芯片肝脏模型
- 批准号:
10752839 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
Subcellular-targeted CYP2E1 and alcohol in the brain
大脑中亚细胞靶向 CYP2E1 和酒精
- 批准号:
10496067 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
microRNA-483 regulation of pancreatic beta-cell function and identity
microRNA-483 对胰腺 β 细胞功能和身份的调节
- 批准号:
10580237 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
Pulmonary implications of perinatal acetaminophen exposure
围产期对乙酰氨基酚暴露对肺部的影响
- 批准号:
10593099 - 财政年份:2022
- 资助金额:
$ 24.89万 - 项目类别:
Pulmonary implications of perinatal acetaminophen exposure
围产期对乙酰氨基酚暴露对肺部的影响
- 批准号:
10755924 - 财政年份:2022
- 资助金额:
$ 24.89万 - 项目类别: